dipeptidase 1: Clinical Trials

3 trials of dipeptidase 1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1

Follow dipeptidase 1: new trials by email Literature Review of dipeptidase 1 trials Research Report on dipeptidase 1

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity
MOTS-c (MDP), Placebo, Route Subcutaneous injection - Prediabetes, Insulin Resistance
Phase 2RecruitingHudson Biotech1202026-02-022026-04-01
Multidimensional Characterization of Dyspnea in Children
Multidimentional observation scale (MDP) - Dyspnea and Respiratory Insufficiency in Children
RecruitingAssistance Publique - Hôpitaux de Paris4002023-01-262025-12-09
Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
incomplete Freund's adjuvant, melanoma helper peptide vaccine, multi-epitope melanoma peptide vaccine - Melanoma (Skin)
Phase 2CompletedEastern Cooperative Oncology Group1752005-05-092023-06-28

Conditions studied

Dyspnea (1)  ·  Insulin Resistance (1)  ·  Melanoma (1)  ·  Metabolic Syndrome (1)  ·  Obesity (1)  ·  Overweight (1)  ·  Prediabetic State (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Eastern Cooperative Oncology Group (1)  ·  Hudson Biotech (1)

Countries

China (1)  ·  France (1)  ·  United States (1)

Top investigators

Craig L. Slingluff, MD (1)

NIH funding

U10CA021115 (1)